A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a ...
AIX-EN-PROVENCE, France--(BUSINESS WIRE)--After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the DDW Convention in San Diego and the EASL Conference in ...
AIX-EN-PROVENCE, France--(BUSINESS WIRE)--E-Scopics, the France-based medical ultrasound company and creator of a unique software-based liver assessment tool, welcomed the announcement that Madrigal ...
Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...
New European and Latin American guidelines on the use of noninvasive tests for liver evaluation are the first to specifically address an approach that has become the standard in much of the developed ...
Giacomo Germani, M.D.; Prodromos Hytiroglou, M.D.; Anastasia Fotiadu, M.D.; Andrew K. Burroughs, F.Med.Sci.; Amar P. Dhillon, M.D. The liver biopsy specimen ...
There remain liver-related safety concerns, regarding potential hepatotoxicity in humans, induced by green tea intake, despite being supposedly beneficial. Although many randomized controlled trials ...
E-Scopics’ Ultraportable, Software-Based Hepatoscope In Use Across Leading Institutions and Clinics AIX-EN-PROVENCE, France, June 20, 2025--(BUSINESS WIRE)--After successfully exhibiting its unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback